Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 106 · FY2023 274 · FY2024 857 — 3-yr total 1,237
Operates in Pharma. Per the activity note to the FY2024 annual report, the company wholesales and manufactures food additives and dyes.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 158 | 249 | 48 | 239 | 87 | 554 | 30 | -24.4% |
| Net Cash used in Investing Activities | 870 | 45 | 11 | 4 | 9 | 194 | 330 | -14.9% |
| Free Cash Flow (OCF − Capex proxy) | 1,028 | 204 | 38 | 235 | 96 | 360 | 360 | -16.1% |
| Net Cash from Financing Activities | 1,070 | 121 | 0 | 304 | 132 | 283 | 523 | -11.2% |
| Net Change in Cash (before FX) | 42 | 83 | 38 | 539 | 228 | 76 | 164 | +25.7% |
| Effect of FX on Cash | 14 | 5 | 22 | 69 | 82 | 3 | 55 | nmf |
| Net Change in Cash (incl. FX) | 28 | 88 | 60 | 471 | 310 | 73 | 218 | +40.9% |
| Cash at Beginning of Year | 34 | 62 | 150 | 209 | 680 | 370 | 443 | +53.4% |
| Cash at End of Year | 62 | 150 | 209 | 680 | 370 | 443 | 661 | +48.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →